Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Pfizer 2014 guidance threatened by Celebrex competition

Court overturns key patent for osteoarthritis drug

- PMLiVE

Pharma’s winners and losers in 2013

Roche, Johnson & Johnson and Amgen rise up the PMLiVE Top Pharma List rankings

- PMLiVE

MedImmune appoints Dr Anand Subramony

He joins from Novartis to take up drug delivery and device development role

- PMLiVE

Communiqué 2014 entry deadline looms

First entries for the PR and medical communications awards close in one week

GCI Health backs growth with new talent

Sherry Goldberg, Allison Schneider and Kimberly Ryan join agency

- PMLiVE

PatientsLikeMe pushes data sharing

The ‘Data for Good’ campaign will encourage health data sharing to advance medical research

- PMLiVE

Uptake challenges for personalised medicines and companion diagnostics

Are healthcare systems ready for joint assessment?

- PMLiVE

Uptake challenges for personalised medicines and companion diagnostics

Are healthcare systems ready for joint assessment?

- PMLiVE

Pfizer still number one – just

The PMLiVE Top Pharma List is updated with a ranking of the 25 biggest companies in the industry

- PMLiVE

No price ceiling for rare disease drugs, say MPs

BIA survey comes ahead of consultation on evaluation framework for ultra-orphans

- PMLiVE

Alderley Park ‘will remain flagship bioscience location’

Manchester Science Parks takes over former AstraZeneca site

- PMLiVE

FDA approves migraine headband

STX-Med’s electronic Cefaly device offers drug-free treatment option

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links